Discure Technologies Overview
Discure Technologies developed a minimally invasive device to treat and reverse degenerative disc disease, reducing pain and restoring functionality to the patient. The system is designed to eliminate the need for invasive surgery and reduce the use of opioids.
Cumulative Funding Raised Over Time ($)
$5.0MMar 2022
$10.0MSep 2024
$21.0MSep 2024
Latest News
growth-positive
Discure Technologies raises $16 million for degenerative disc disease treatment | CTech
Discure Technologies has successfully completed $16 million in financing to advance its treatment for degenerative disc disease (DDD). The funding includes $11 million from an oversubscribed Series A round and $5 million from a SAFE raise. The Series A round was led by BOLD Capital Partners, Supernova Invest, and Sanara Capital, with participation from U.S. hospital networks, orthopedic surgeons, and medtech investors. The investment will accelerate the companys growth, allowing it to make key hires and fully fund its First-in-Human clinical study in Canada and Italy. Discures novel approach aims to shift the paradigm from symptom management to regenerating the disc.
InvestmentPartnersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $21M |
| Last funding | $11M |
| Stage | A |
| Rounds | 3 |
| Investors | 7 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | discuremd.com |
Locations
Medinat HaYehudim Street 85, Herzliya, Israel
Photos & Videos
1 item(s)
Discure Technologies Business
Business models
B2C
Product stage
R&D
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersCore Technology
Materials & SubstancesImplantsTags (5)
medical-technologiesmedical-deviceshealthcareminimally-invasivedegenerative-diseasesDiscure Technologies Financials
$21M
Total funding
Undisclosed
Capital raised
$11M
Last funding
A
Funding stage
3
Total rounds
7
Investors
Cumulative Funding Raised Over Time ($)
$5.0MMar 2022
$10.0MSep 2024
$21.0MSep 2024
Private Equity Funding
SAFE
Sep 2024
$5M
Sanara Capital, Bold Capital Partners, Supernova Invest
A Round
Sep 2024
$11M
Bold Capital Partners (Lead)
,
Supernova Invest, Sanara Capital
Seed
Mar 2022
$5M
Rainbow Medical (Lead)
,
Johnson & Johnson Innovation, Katao Venture Partners, KYTO
Discure Technologies Lifecycle
Cumulative Funding Raised Over Time
$5.0MMar 2022
$10.0MSep 2024
$21.0MSep 2024
All Events
SAFE
Sep 2024
$5M
Sanara Capital, Bold Capital Partners, Supernova Invest
A Round
Sep 2024
$11M
Bold Capital Partners (Lead)
,
Supernova Invest, Sanara Capital
Seed
Mar 2022
$5M
Rainbow Medical (Lead)
,
Johnson & Johnson Innovation, Katao Venture Partners, KYTO
Discure Technologies News
1 article
growth-positive
Discure Technologies raises $16 million for degenerative disc disease treatment | CTech
Discure Technologies has successfully completed $16 million in financing to advance its treatment for degenerative disc disease (DDD). The funding includes $11 million from an oversubscribed Series A round and $5 million from a SAFE raise. The Series A round was led by BOLD Capital Partners, Supernova Invest, and Sanara Capital, with participation from U.S. hospital networks, orthopedic surgeons, and medtech investors. The investment will accelerate the companys growth, allowing it to make key hires and fully fund its First-in-Human clinical study in Canada and Italy. Discures novel approach aims to shift the paradigm from symptom management to regenerating the disc.
InvestmentPartnersExpand
Discure Technologies Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 11 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Discure Technologies Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | markets |
| Registrar ID | 516554326 |
| Creator | Yuval Mandelbaum |
| Creator email | yuvalrainbow@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-02-20T00:00:00.000Z |
| Created | 2020-12-17T00:00:00.000Z |
| Claimed | Yes |